Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/106121
DC FieldValueLanguage
dc.contributor.authorJorge, Ludmilla R.-
dc.contributor.authorHarada, Liliam K.-
dc.contributor.authorSilva, Erica C.-
dc.contributor.authorCampos, Welida F.-
dc.contributor.authorMoreli, Fernanda C.-
dc.contributor.authorShimamoto, Gustavo-
dc.contributor.authorPereira, Jorge F. B.-
dc.contributor.authorOliveira, José M-
dc.contributor.authorTubino, Matthieu-
dc.contributor.authorVila, Marta M. D. C.-
dc.contributor.authorBalcão, Victor M.-
dc.date.accessioned2023-03-21T11:58:42Z-
dc.date.available2023-03-21T11:58:42Z-
dc.date.issued2020-
dc.identifier.issn1663-9812pt
dc.identifier.urihttps://hdl.handle.net/10316/106121-
dc.description.abstractIn this research project, synthesis and characterization of ionic liquids and their subsequent utilization as facilitators of transdermal delivery of human insulin was pursued. Choline geranate and choline oleate ionic liquids (and their deep eutectic solvents) were produced and characterized by nuclear magnetic resonance (1H NMR), water content, oxidative stability, cytotoxicity and genotoxicity assays, and ability to promote transdermal protein permeation. The results gathered clearly suggest that all ionic liquids were able to promote/facilitate transdermal permeation of insulin, although to various extents. In particular, choline geranate 1:2 combined with its virtually nil cyto- and geno-toxicity was chosen to be incorporated in a biopolymeric formulation making it a suitable facilitator aiming at transdermal delivery of insulin.pt
dc.language.isoengpt
dc.publisherFrontiers Media S.A.pt
dc.relationFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, São Paulo, Brazil) [FAPESP Refs. No. 2016/08884-3 (Project PneumoPhageColor), 2016/12234-4 (Project TransAppIL), and 2018/05522-9 (Project PsaPhageKill, in the form of a BPE fellowship granted to VB)]pt
dc.relationCNPq, National Council for Scientific and Technological Development Brazil, in the form of Research Productivity (PQ) fellowships granted to VB (Refs. No. 306113/2014-7 and 308208/2017-0)pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjecthuman insulinpt
dc.subjectionic liquidspt
dc.subjectcholine geranatept
dc.subjectcholine oleatept
dc.subjecttransdermal permeationpt
dc.subjectchemical and biological characterizationpt
dc.titleNon-invasive Transdermal Delivery of Human Insulin Using Ionic Liquids: In vitro Studiespt
dc.typearticle-
degois.publication.firstPage243pt
degois.publication.titleFrontiers in Pharmacologypt
dc.peerreviewedyespt
dc.identifier.doi10.3389/fphar.2020.00243pt
degois.publication.volume11pt
dc.date.embargo2020-01-01*
uc.date.periodoEmbargo0pt
item.openairetypearticle-
item.fulltextCom Texto completo-
item.languageiso639-1en-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.orcid0000-0001-5959-0015-
Appears in Collections:I&D CIEPQPF - Artigos em Revistas Internacionais
Show simple item record

SCOPUSTM   
Citations

45
checked on Jul 15, 2024

WEB OF SCIENCETM
Citations

44
checked on Jul 2, 2024

Page view(s)

56
checked on Jul 16, 2024

Download(s)

29
checked on Jul 16, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons